Novel phosphorus heterocyclic compounds, 3-methyl-l-(3-bromophenyl as well as some 3-substituted phenyl)-2-phospholene 1-oxides (Id as well as lb, lc, and If), were synthesized from l-phenyl-2-phospholene 1-oxide la via 3-methyl-l-(3-nitrophenyl)-2-phospholene 1-oxide (lb). l-(4-Bromophenyl)-2-phospholene le was prepared by Grignard coupling reaction of l-chloro-3-methyl-2-phospholene 1-oxide with 4-bromophenylmagnesium bromide. 2,3-Dfbromo-3-methyI-l-arylphospholane 1-oxides (2a-2e) were prepared by the addition reaction of bromine to the C=C double bond of 2-phospholenes la-le. The substituent effect of the phenyl group of the 1-aryl-phospho lanes 2 on the observed anti-proliferative effect against U937 leukemia cell lines evaluated by MTT in vitro methods showed that 2,3-dibromo-3-methyl-l-(4-bromophenyl)phospholane (2e) was the most active among 2. These novel dibromophosphorus heterocyclic derivatives exhibit much higher anti-cancer activity than Gleevec® (molecular targeting chemotherapeutic agent) against U937 cells.
INTRODUCTION
Phospha sugars /1-3/, one new category of the pseudo sugars which have a phosphorus atom in the hemiacetal ring of sugars, are not yet found in nature and the synthesis of them are rather difficult compared with the typical pseudo sugars.
Phospha sugars exert important biological activities and have quite efficient anti-cancer activities for leukemia cells /4/.
By the further research on phospha sugar anti-tumor agents, it may be more plausible that the medicinal chemistry will lead to find novel phospha sugars as multi-molecular targeting chemotherapeutic drugs for the human cancers, and then researches on the synthesis and evaluation of phospha sugars as a new type of molecular targeting chemotherapeutic Vol. 16, Nos. [2] [3] 2010 Synthesis of Some l-Aryl-2,3-dibromophospholanes As Novel anti-tumor agents will be developed. In this paper, we will deal with the preparation of derivatives of l-aryl-2-phospholenes 1 and l-aryl-2,3-dibromophospholanes 2, and the evaluation of their anti-cancer activity by MTT in vitro methods against leukemia cells. 
RESULTS AND DISCUSSION
The syntheses of various l-aryl-2,3-dibromo-3-methyl-2-phospholene 1-oxide (lb-lf), with one of the substituents of 3-nitro, 3-cyano, 3-bromo, and 3-amino groups, were performed by substitution reaction on the phenyl group of 1-phenyl-2-phospholene la (Scheme 1). Synthesis of 3-methyl-l-phenyl-2-phospholene 1-oxide (la) was carried out by a known [4+2] cycloaddition reaction of 2-methyl-l,3-butadiene with phenylphosphonous dichloride and the successive hydrolysis reaction of the [4+2] cycloadduct (McCormac reaction Ι5Γ) in yield of 68% (Scheme 1, step (i)). 3-MethyI-lphenyI-2-phospholene la was converted into 3-methyl-l-(3-nitrophenyl)-2-phospholene lb, in which the nitro group replaced selectively at the 3-position of the phenyl by an action of fuming nitric acid and concentrated sulfuric acid in yield of 97% (Scheme 1, step (ii)). 3-Methyl-l-(3-aminophenyl)-2-phospholene If was prepared from l-(3-nitrophenyl)-2-phospholene lb by the reduction of the nitro group with tin chloride and concentrated hydrochloric acid in yield of 88% (Scheme 1, step (iii)). 3-Methyl-l-(3-cyanophenyl)-2-phospholene lc was prepared from l-(3-aminophenyl)-2-phospholene If by the Sandmeyer reaction of the amino group with sodium nitrite, concentrated sulfuric acid, and copper(I) cyanide in yield of 66% (Scheme 1, step (iv)). Similarity, 3-methyl-l-(3-bromophenyl)-2-phospholene Id was prepared from l-(3-aminophenyl)-2-phospholene If by the Sandmeyer reaction of the amino group with sodium nitrite, concentrated sulfuric acid and copper(II) bromide in yield of 47% (Scheme 1, step (v)).
3-Methyl-l-(4-bromophenyl)-2-phospholene 1-oxide (le) was prepared from l-chloro-3-methyl-2-phospholene 1-oxide by the Grignard coupling-reaction using 4-bromophenylmagnesium bromide in yield of 64%. l-Aryl-2,3-dibromo-3-methylphospholane 1-oxides (2a-2e), where the phenyl group was substituted by either one of substituents of 3-nitro, 3-cyano, 3-bromo, and 4-bromo groups, were prepared by an addition reaction of bromine to l-aryl-3-methyl-2-phospholene 1-oxide (la-le).
The addition reaction of bromine to the electron deficient C=C double bond of 2-phospholene 1 was accelerated by a manganese or copper catalyst. The reaction conditions and the results for preparation of 2a-2e are summarized in Table 1 
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Synthesis of Some l-Aryl-2,3-dibromophospholanes As Novel Table 1 Preparation of I-aryI-3-methyl-2-phosoholene 1-oxides la-lf and l-aryl-2,3-dibromo-3-methyl-2-phospholane 1-oxides 2a-2e. Table 2 ). The observed anti-proliferative effect of dibromo derivatives 2a-2e on U937 cells observed was much more efficient than that of Gleevec® (IC 50 = 500 μΜ) /6-9/. The effect of increase in the number of bromo substituents in the phospha sugars or phopholane derivatives 2 suggests the decrease of the IC 50 and a good anti-proliferative effect. Substituent effects of bromo groups in heterocyclic compounds and/or aromatic compounds on improvement of bioactivities of meridianins and isatin derivatives, which activates protein kinase inhibitory effects and induces apoptosis, are reported/10,11/. These protein kinase inhibitory effects are important for drugs for targeting oncology/12/. The substituent effect of the phenyl group on IC 50 seems to be influenced either by electronic and steric factors of the substituents. cells.
In conclusion, we have synthesized novel dibromophospholane derivatives, l-aryl-2,3-dibromo-3-methyl-2-phospholane 1-oxides 2b-2e substituted by either one substituents of 3-nitro, 3-cyano, 3-bromo, and 4-bromo groups on the phenyl group, in good yields by addition reaction of bromine in the presence of catalyst. MTT in vitro bio-assay method revealed that the prepared phosphorus heterocyclic compounds 2a-2e, especially 2,3-dibromo-3-methyl-l-(3-bromophenyl)phospholane 1-oxide (2d), have quite efficient anti-cancer activities for leukemia cells in manners of (i) wide spectra, (ii) high activities, and (iii) high specificities and selectivities. 
Synthesis of Phosphorus Heterocyclic Compounds:

Synthesis of 3-methyl-l-phenyl-2-phospholene 1-oxide (la):
Isoprene 70 ml (0.398 mol) and phenylphosphonous dichloride 68 ml (0.663 mol) were mixed and reacted at room temperature for 2 weeks. The formed solid, 3-methyl-l-phenyl-2-phospholenium dichloride, was dissolved in chloroform and hydrolized at 0 °C. The reaction mixture was neutralized with sodium hydrogencarbonate and then filtered and extracted with chloroform (3 χ 15 ml). The chloroform extarct was washed with saturated sodium hydrogencarbonate solution (50 ml) and saturated sodium chloride solution (50 ml). Drying over the chloroform extarct with anhydrous sodium sulfate followed by filtration, evapolation of the solvent in vacuo, and distillation under the reduced pressure afforded 3-methyl-1-phenyl-2-phospholene 1-oxide (la: Registry number: 707-61-9; 64 g) in 68%
yield. 
Synthesis o/3-methyl-I-(3-nitrophenyl)-2-phospholene 1-oxide (lb):
To a sulfuric acid solution (1 ml) of 2-phospholene la (192 mg, 1.00 mmol) was added fuming nitric acid (0.089
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Synthesis of Some l-Aryl-2,3-dibromophospholanes As Novel ml), and then the mixture was kept at room temperature for 30 min with stirring. To the reaction miture was added ice/water and extracted with chloroform (10 ml χ 3). The chloroform extract was washed with water (10 ml χ 1) and saturated sodium chloride solution (10 ml χ 1), and then dried over with anhydrous sodium sulfate. Filtration of the chloroform extarct and evaporation of the filtrate gave the residue, which was column chromatographed (silica gel; eluent: chloroform: methanol = 20 : 1) to give 3-methyl-l-(3-nitrophenyl)- 
Synthesis of 3-methyl-l-(3-aminophenyl)-2-phospholene 1-oxide (If):
To chloroform solution (10 ml) of nitric acid (0.089 ml) of 2-phospholene lb (4.50 mg, 19.9 mmol) was added 
Synthesis of 3-methyl-l-(3-bromophenyl)-2-phospholene 1-oxide (Id):
To a diluted sulfuric acid solution (water (2 ml) and sulfuric acid (1 ml)) of 2-phospholene If (0.36 g, 1.7 mmol) was added concentrated sulfuric acid (2 ml), and then sodium nitrite (0.12 g, 1.0 eq) solution was added dropwise for 5 min at 0 °C with stirring to prepare the diazonium salt. To the hydrobromic acid solution (1 ml) of copper(I) bromide (0.49 g, 2.0 eq) was added drop wisely the diazonium salt solution at 0 °C with stirring. After the reaction (Sandmayer reaction) for 5 min, the reaction mixture was extracted with chloroform (10 ml χ 3), and then the extract was washed with sodium hydrogencarbonate (10 ml χ 2) and saturated sodium chloride solution. Drying over the chloroform extract with anhydrous sodium sulfate followed by filtration and evaporation of the solvent in vacuo gave the residual product, 
Synthesis of 3-methyl-l-(3-cyanophenyl)-2-phospholene 1-oxide (lc):
The 
Synthesis of3-methyl-l-(4-bromophenyl)-2-phospholene 1-oxide (le):
To a dry THF solution (15 ml) of l-chloro-3-methyl-2-phospholene 1-oxide (4.70 g, 31.2 mmol: prepared from 1-methoxy-3-methyl-2-phospholene 1-oxide) was added 4-bromophenylmagnesium bromide (prepared from 4-dibromobenzene (9.58 g, 40.6 mmol) and magnesium (0.99 g, 40.6 mmol) in dry THF (20 ml)) under the argon atmosphere and reacted at room temperature for 4 h with stirring. The reaction mixture was treated with 10% hydrochloric acid and neutralized, and then THF of the reaction medium was evaporated. The residual solution was extracted with ethyl acetate (30 ml χ 3) and the extract was washed with saturated sodium hydrogencarbonate solution and saturated sodium chloride solution. Drying the ethyl acetate extract over anhydrous sodium sulfate followed by filtration and evapolation in vacuo gave residual product, which was column chromatographed (silica gel; eluent: chloroform : methanol = 10 : 1) to afford 3-methyl-l-(4-bromophenyl)- 
Synthesis of2,3-dibromo-3-methyl-l-(3-nitrophenyl)-phospholane 1-oxide (2b):
To a dichloromethane solution (5 ml) of 2-phospholene lb (0.20 g, 1.00 mmol) was added manganese(II) bromide (0.19 g, 1.0 mmol; 1.0 eq), and then to the mixture was added dichloromethane solution (10 ml) of bromine (0.5 ml, excess) dropwisely for 20 min with stirring at room temperature. After the reaction, saturated sodium hydrogensulfite solution was added to reduce the excees amount of bromine and was extracted with chloroform. Neutralization of the chloroform extract with saturated sodium hydrogencarbonate solution followed by washing the chloroform layer with saturated sodium chloride, drying over with anhydrous sodium sulfate, filtration, and evapolation of the solvent gave the residual product. The column chromatography on silica gel (eluent: chloroform : methanol = 30 : 1) afforded colorless crystaline 2,3-dibromo-3-methyl-l-(3-nitrophenyl)phospholane 1-oxide (2b, 0.40 g) in 96% yield. Similarly, l-aryl-2,3-dibromo-3-methylphospholane 1-oxides (2a, and 2c-2e) were prepared. 
MTT in vitro Evaluation:
Reagent and solvent for the in vitro MTT evaluation: l-Aryl-2,3-dibromo-3-methylphospholane 1-oxides 2a-2e, the reagents being evaluated by the in vitro MTT method, were dissolved in dimethylsulfoxide (DMSO) (Sigma Chemical Company, St. Louis, MO, USA) as the solvent, and the solutions were diluted into appropriate concentration with DMSO in culture medium immediately before use. The final concentrations of 2 in DMSO in all experiments were less than 0.010%, and all the treatment conditions were compared with vehicle controls. The control experiments for the evaluation were carried out by using DMSO, and the absorption change by DMSO in the MTT method was not observed for U937 cells as well as K562 cells at 37 °C for 48 h.
